Allurion Technologies, Inc. (ALUR) EBITDA
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$3.73M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$9.63M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$6.95M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income -$7.28M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | -$3.73M | (m) | $2.95M | (m) | (m) | -$3.22M | (m) | $912.00K | (m) | $22.00K |
| 2025-09-30 | Reported | (m) | -$9.63M | (m) | $2.66M | (m) | (m) | -$6.54M* | (m) | $2.02M | (m) | $9.00K |
| 2025-06-30 | Reported | (m) | -$6.95M | (m) | $3.38M | (m) | (m) | -$7.61M* | (m) | $1.80M | (m) | $43.00K |
| 2025-03-31 | Reported | (m) | -$7.28M | (m) | $5.58M | (m) | (m) | -$9.47M | (m) | $2.62M | (m) | $95.00K |
| 2024-09-30 | Reported | (m) | -$12.34M | (m) | $5.37M | (m) | $72.00K* | -$11.46M* | (m) | $3.21M | (m) | $69.00K |
| 2024-06-30 | Reported | (m) | -$9.35M | (m) | $11.77M | (m) | $435.00K* | -$8.93M* | (m) | $4.31M | (m) | $65.00K |
| 2024-03-31 | Reported | (m) | -$11.39M | (m) | $9.39M | (m) | $104.00K | -$8.64M | (m) | $5.72M | (m) | $76.00K |
| 2023-09-30 | Reported | (m) | -$26.15M | (m) | $18.20M | (m) | $800.00K* | -$23.09M* | (m) | $7.19M | (m) | $34.00K |
| 2023-06-30 | Reported | (m) | -$13.29M | (m) | $12.96M | (m) | $131.00K* | -$9.70M* | (m) | $6.58M | (m) | $22.00K |
| 2023-03-31 | Reported | (m) | -$13.89M | (m) | $14.07M | (m) | $277.00K | -$10.32M | (m) | $7.85M | (m) | $34.00K |
| 2022-09-30 | Reported | (m) | -$11.98M | (m) | $16.06M | (m) | -$157.00K* | -$10.13M* | (m) | $5.07M | (m) | $95.00K |
| 2022-06-30 | Reported | (m) | -$4.29M | (m) | $16.25M | (m) | (m) | (m) | (m) | $3.10M | (m) | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$30.16M | (m) | $15.23M | (m) | (m) | -$28.95M | (m) | $7.57M | (m) | $74.00K |
| 2024-12-31 | Reported | (m) | -$50.20M | (m) | $32.11M | (m) | $611.00K | -$42.30M | (m) | $17.37M | (m) | $718.00K |
| 2023-12-31 | Reported | (m) | -$79.08M | (m) | $53.47M | (m) | $1.61M | -$63.98M | (m) | $27.69M | (m) | $264.00K |
| 2022-12-31 | Reported | (m) | -$32.01M | (m) | $64.21M | (m) | $1.55M | -$46.98M | (m) | $16.97M | (m) | $143.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |